Correlation Between Design Therapeutics and Amarin PLC

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Design Therapeutics and Amarin PLC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Design Therapeutics and Amarin PLC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Design Therapeutics and Amarin PLC, you can compare the effects of market volatilities on Design Therapeutics and Amarin PLC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Design Therapeutics with a short position of Amarin PLC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Design Therapeutics and Amarin PLC.

Diversification Opportunities for Design Therapeutics and Amarin PLC

-0.51
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Design and Amarin is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding Design Therapeutics and Amarin PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Amarin PLC and Design Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Design Therapeutics are associated (or correlated) with Amarin PLC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Amarin PLC has no effect on the direction of Design Therapeutics i.e., Design Therapeutics and Amarin PLC go up and down completely randomly.

Pair Corralation between Design Therapeutics and Amarin PLC

Given the investment horizon of 90 days Design Therapeutics is expected to under-perform the Amarin PLC. In addition to that, Design Therapeutics is 1.29 times more volatile than Amarin PLC. It trades about -0.16 of its total potential returns per unit of risk. Amarin PLC is currently generating about 0.12 per unit of volatility. If you would invest  52.00  in Amarin PLC on November 2, 2024 and sell it today you would earn a total of  5.64  from holding Amarin PLC or generate 10.85% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy95.0%
ValuesDaily Returns

Design Therapeutics  vs.  Amarin PLC

 Performance 
       Timeline  
Design Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Design Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, Design Therapeutics is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.
Amarin PLC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Amarin PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Amarin PLC is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Design Therapeutics and Amarin PLC Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Design Therapeutics and Amarin PLC

The main advantage of trading using opposite Design Therapeutics and Amarin PLC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Design Therapeutics position performs unexpectedly, Amarin PLC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amarin PLC will offset losses from the drop in Amarin PLC's long position.
The idea behind Design Therapeutics and Amarin PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Complementary Tools

Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance